GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 371 filers reported holding GLOBUS MED INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,473,073 | +10.4% | 251,220 | +32.4% | 0.03% | -22.0% |
| Q2 2023 | $11,294,381 | +76.9% | 189,694 | +68.3% | 0.04% | -57.3% |
| Q1 2023 | $6,384,291 | -49.5% | 112,717 | -33.7% | 0.10% | -58.3% |
| Q4 2022 | $12,632,584 | -10.3% | 170,090 | -28.0% | 0.23% | -14.5% |
| Q3 2022 | $14,079,000 | +303.9% | 236,348 | +280.6% | 0.27% | +180.2% |
| Q2 2022 | $3,486,000 | -69.7% | 62,097 | -60.1% | 0.10% | -68.7% |
| Q1 2022 | $11,489,000 | +40.2% | 155,726 | +37.2% | 0.31% | +20.4% |
| Q4 2021 | $8,196,000 | +74.0% | 113,515 | +84.6% | 0.26% | +90.3% |
| Q3 2021 | $4,711,000 | -20.1% | 61,484 | -19.2% | 0.13% | -33.3% |
| Q2 2021 | $5,898,000 | +38.5% | 76,080 | +10.1% | 0.20% | -18.6% |
| Q1 2021 | $4,260,000 | +28.0% | 69,080 | +35.4% | 0.25% | +11.3% |
| Q4 2020 | $3,328,000 | – | 51,025 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |